Inventor · disambiguated record
Brian Mckittrick
Also filed as: MCKITTRICK BRIAN · MCKITTRICK BRIAN A · MCKITTRICK BRIAN ALEXANDER
68 granted patents·11 pending applications·1,646 citations·filing 1987–2017
99Inventor score
Top patents by PatentIndex Score
79 records- 0198US5767115AHydroxy-substituted azetidinone compounds useful as hypocholesterolemic agentsSCHERING PLOUGH CORP·Filed 1996·Granted Jun 16, 1998·267 cites·9 claims
- 0297US6689765B2Piperazine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2002·Granted Feb 10, 2004·71 cites·12 claims
- 0397USRE37721EHydroxy-substituted azetidinone compounds useful as hypocholesterolemic agentsSCHERING CORP·Filed 2000·Granted May 28, 2002·99 cites·13 claims
- 0497US6391865B1Piperazine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2000·Granted May 21, 2002·94 cites·19 claims
- 0597US5846966ACombinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase InhibitorsSCHERING CORP·Filed 1997·Granted Dec 8, 1998·171 cites·10 claims
- 0696US5624920ASulfur-substituted azetidinone compounds useful as hypocholesterolemic agentsSCHERING CORP·Filed 1994·Granted Apr 29, 1997·88 cites·15 claims
- 0795US7763609B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2007·Granted Jul 27, 2010·38 cites·12 claims
- 0895US6387930B1Piperidine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2000·Granted May 14, 2002·76 cites·13 claims
- 0995US5939419A2-benzyl-polycyclic guanine derivatives and process for preparing themSCHERING PLOUGH CORP·Filed 1994·Granted Aug 17, 1999·83 cites·9 claims
- 1095US5744467ASulfur-substituted azetidinone compounds useful as hypocholesterolemic agentsSCHERING CORP·Filed 1997·Granted Apr 28, 1998·77 cites·12 claims
- 1194US7884080B2Azetidinone derivatives and methods of use thereofSCHERING PLOUGH CORP·Filed 2007·Granted Feb 8, 2011·46 cites·23 claims
- 1294US5824683A2'- 4'-halo- 1,1'-biphenyl!-4-yl!methyl!-5'-methyl-spiro cyclopentane-1,7' (8'H)- 3H! imidazo 2,1-b!purin!-4' (5'H)-onesSCHERING CORP·Filed 1996·Granted Oct 20, 1998·70 cites·6 claims
- 1391US7700601B2Substituted indazoles of formula 1.0 that are kinase inhibitorsSCHERING CORP·Filed 2007·Granted Apr 20, 2010·38 cites·14 claims
- 1491US5633246ASulfur-substituted azetidinone compounds useful as hypocholesterolemic agentsSCHERING CORP·Filed 1995·Granted May 27, 1997·91 cites·15 claims
- 1590US7868000B2Aspartyl protease inhibitorsSCHERING CORP·Filed 2006·Granted Jan 11, 2011·18 cites·45 claims
- 1690US6458812B1Muscarinic antagonistsSCHERING CORP·Filed 2001·Granted Oct 1, 2002·56 cites·14 claims
- 1788US7700603B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2005·Granted Apr 20, 2010·9 cites·8 claims
- 1886US8829036B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Sep 9, 2014·7 cites·3 claims
- 1986US7973067B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2008·Granted Jul 5, 2011·6 cites·22 claims
- 2086US7528132B2Kinase inhibitorsSCHERING CORP·Filed 2006·Granted May 5, 2009·14 cites·35 claims
- 2185US8691831B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·18 claims
- 2285US8691833B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·9 claims
- 2385US6602885B2Piperidine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2001·Granted Aug 5, 2003·21 cites·17 claims
- 2484US7763606B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2006·Granted Jul 27, 2010·5 cites·16 claims
- 2584US7592348B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2004·Granted Sep 22, 2009·16 cites·41 claims
- 2684US7468372B2Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2006·Granted Dec 23, 2008·7 cites·13 claims
- 2783US8012960B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2010·Granted Sep 6, 2011·5 cites·19 claims
- 2883US7638526B2Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolismSCHERING CORP·Filed 2007·Granted Dec 29, 2009·8 cites·6 claims
- 2982US7652020B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Jan 26, 2010·5 cites·48 claims
- 3082US7560451B2Aspartyl protease inhibitorsSCHERING CORP·Filed 2006·Granted Jul 14, 2009·5 cites·20 claims
- 3182US6472394B1MCH antagonists and their use in the treatment of obesitySCHERING CORP·Filed 2001·Granted Oct 29, 2002·24 cites·12 claims
- 3281US7759353B2Substituted spiro iminopyrimidinones as aspartyl protease inhibitors, compositions, and methods of treatmentSCHERING CORP·Filed 2006·Granted Jul 20, 2010·5 cites·14 claims
- 3381US7759354B2Bicyclic guanidine derivatives as asparyl protease inhibitors, compositions, and uses thereofSCHERING CORP·Filed 2006·Granted Jul 20, 2010·5 cites·19 claims
- 3480US7459450B2Neuropeptide receptor modulatorsSCHERING CORP·Filed 2005·Granted Dec 2, 2008·5 cites·29 claims
- 3579US7723342B2Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemiaSCHERING CORP·Filed 2006·Granted May 25, 2010·4 cites·61 claims
- 3678US8927559B2Quinazolinone-type compounds as CRTH2 antagonistsASLANIAN ROBERT G·Filed 2011·Granted Jan 6, 2015·6 cites·16 claims
- 3778US7384944B2Piperazine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2003·Granted Jun 10, 2008·6 cites·18 claims
- 3878US6838466B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2002·Granted Jan 4, 2005·10 cites·41 claims
- 3977US8242112B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2011·Granted Aug 14, 2012·2 cites·4 claims
- 4077US7592419B2Macrocyclic inhibitors of hepatitis C virus NS3-serine proteaseSCHERING CORP·Filed 2004·Granted Sep 22, 2009·11 cites·36 claims
- 4177US7084271B2Pyrazolopyrimidines as cyclin dependent kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Aug 1, 2006·9 cites·28 claims
- 4276US8426403B2Gamma secretase modulatorsZHU ZHAONING·Filed 2008·Granted Apr 23, 2013·2 cites·9 claims
- 4374US8765757B23-heterocyclic substituted indole derivatives and methods of use thereofCHAN TIN-YAU·Filed 2008·Granted Jul 1, 2014·4 cites·20 claims
- 4474US8178513B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2009·Granted May 15, 2012·1 cites·13 claims
- 4574US8168641B2Aspartyl protease inhibitorsWU YUSHENG·Filed 2007·Granted May 1, 2012·2 cites·21 claims
- 4672US7902157B2Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolismSCHERING CORP·Filed 2007·Granted Mar 8, 2011·1 cites·23 claims
- 4771US5476847ADerivatives of phosphinic acid useful as endothelin converting enzyme inhibitorsSCHERING CORP·Filed 1994·Granted Dec 19, 1995·25 cites·29 claims
- 4870US8722708B2Substituted isoindolines as aspartyl protease inhibitorsSTAMFORD ANDREW·Filed 2006·Granted May 13, 2014·2 cites·9 claims
- 4969US8629155B2Aspartyl protease inhibitorsWU YUSHENG·Filed 2012·Granted Jan 14, 2014·1 cites·6 claims
- 5066US8623857B2N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1TSUI HON-CHUNG·Filed 2011·Granted Jan 7, 2014·1 cites·18 claims
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Brian Mckittrick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →